Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects

BACKGROUND: Here, we aimed to investigate the pharmacokinetics of abacavir and carbovir triphosphate (CBV-TP) with darunavir/ritonavir 900/100 mg once daily or raltegravir 400 mg twice daily. METHODS: HIV-infected subjects on abacavir (600 mg once daily) underwent steady-state pharmacokinetic assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jackson, Akil, Moyle, Graeme, Dickinson, Laura, Back, David, Khoo, Saye, Taylor, Jessica, Gedela, Keerti, Abongomera, George, Gazzard, Brian, Boffito, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736319/
https://ncbi.nlm.nih.gov/pubmed/22267465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP1910
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados